Josephine S. Mansell

Rowland Hill Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.

Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.

Journal: JAMA cardiology

Published: August 12, 2026

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders: The EXCALIBUR Study.

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders: The EXCALIBUR Study.

Journal: Journal of the American College of Cardiology

Published: March 23, 2026

Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.

Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.

Journal: Circulation. Cardiovascular imaging

Published: February 12, 2026

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.

Journal: Circulation

Published: February 02, 2026

Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B Trial.

Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B Trial.

Journal: European journal of heart failure

Published: January 14, 2026

Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis.

Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis.

Journal: Kidney international

Published: November 08, 2025

Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm.

Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm.

Journal: Journal of the American College of Cardiology

Published: October 18, 2025

Biochemical triple testing to exclude monoclonal gammopathy for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy.

Biochemical triple testing to exclude monoclonal gammopathy for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy.

Journal: European journal of heart failure

Published: October 01, 2025

Early Diagnosis of ATTR-CM Using Carpal Tunnel Biopsy Examination: EDUCATE: A United Kingdom Prospective Multicenter Study.

Early Diagnosis of ATTR-CM Using Carpal Tunnel Biopsy Examination: EDUCATE: A United Kingdom Prospective Multicenter Study.

Journal: JACC. Heart failure

Published: September 29, 2025

Myocardial Amyloid Burden in Transthyretin Amyloidosis.

Myocardial Amyloid Burden in Transthyretin Amyloidosis.

Journal: Journal of the American College of Cardiology

Published: September 22, 2025

Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial.

Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial.

Journal: Lancet (London, England)

Published: July 25, 2025

Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis.

Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis.

Journal: European journal of heart failure

Published: July 16, 2025

Showing 1-12 of 24

Last Updated: 09/26/2026